Cargando…
CRE: a cost effective and rapid approach for PCR-mediated concatenation of KRAS and EGFR exons: Rapid way to detect EGFR and KRAS mutations
Molecular diagnostics has changed the way lung cancer patients are treated worldwide. Of several different testing methods available, PCR followed by directed sequencing and amplification refractory mutation system (ARMS) are the two most commonly used diagnostic methods worldwide to detect mutation...
Autores principales: | Ramteke, Manoj P., Patel, Kuldeep J, Godbole, Mukul, Vyas, Maulik, Karve, Kunal, Choughule, Anuradha, Prabhash, Kumar, Dutt, Amit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000Research
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4830212/ https://www.ncbi.nlm.nih.gov/pubmed/27127615 http://dx.doi.org/10.12688/f1000research.6663.2 |
Ejemplares similares
-
ERBB2 and KRAS alterations mediate response to EGFR inhibitors in early stage gallbladder cancer
por: Iyer, Prajish, et al.
Publicado: (2018) -
Coexistence of KRAS mutation with mutant but not wild-type EGFR predicts response to tyrosine-kinase inhibitors in human lung cancer
por: Choughule, A, et al.
Publicado: (2014) -
EGFR and KRAS Mutations in Lung Parenchyma of Subjects With EGFR/KRAS Wild-Type Lung Adenocarcinoma
por: Chalela, Roberto, et al.
Publicado: (2021) -
KRAS and EGFR mutations coexisting in lung adenocarcinoma
por: Sousa, Vitor, et al.
Publicado: (2010) -
EGFR and KRAS Mutations in Patients With Adenocarcinoma of the Lung
por: Jang, Tae Won, et al.
Publicado: (2009)